Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery.
We assessed the efficacy of the combination of propranolol and potassium iodide in the preparation of patients with Graves' disease for thyroid surgery. Potassium iodide was given orally in a dose of 60 mg three times a day for 10 days before operation in 10 patients who were already receiving propranolol. In contrast to previous experience with either drug used singly, the combined regimen caused a significant fall in mean serum total thyroxine and triiodothyronine to levels in the euthyroid range before operation (P less than 0.001). There was also a significant fall (P less than 0.05) before operation and transient rise after operation in serum reverse triiodothyronine. These preliminary results suggest that the combination of potassium iodide and propranolol may prove to be the optimum preoperative preparation for patients with Graves' disease.
D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006111:Graves Disease / Q000097:blood / Q000601:surgery*; D006801:Humans; D011193:Potassium Iodide / Q000008:administration & dosage* / Q000494:pharmacology; D011300:Preoperative Care; D011433:Propranolol / Q000008:administration & dosage* / Q000494:pharmacology; D013965:Thyroidectomy; D013974:Thyroxine / Q000097:blood; D013997:Time Factors; D014284:Triiodothyronine / Q000097:blood
D014284:Triiodothyronine; D011193:Potassium Iodide; D011433:Propranolol; D013974:Thyroxine